CAROL BRAUNGART: Open Payments
NPI 1508977398 · NISKAYUNA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $647 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $127 |
| Abbott Laboratories | 5 | $105 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $42 |
| ABBVIE INC. | 2 | $39 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| Viatris Specialty LLC | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: Kerendia, FREESTYLE LIBRE 3, GEMTESA, TZIELD, Rybelsus, YUPELRI, UBRELVY, QULIPTA.
Industry payments across NY — which companies pay providers there.
